blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1129191

EP1129191 - METHODS OF DIAGNOSING OR TREATING NEUROLOGICAL DISEASES [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.03.2007
Database last updated on 29.10.2024
Most recent event   Tooltip05.12.2008Lapse of the patent in a contracting state
New state(s): CY
published on 07.01.2009  [2009/02]
Applicant(s)For all designated states
EVOTEC Neurosciences GmbH
Schnackenburgallee 114
22525 Hamburg / DE
[2005/05]
Former [2005/01]For all designated states
EVOTEC Neurosciences GmbH
Schnackenburgallee 114
22525 Hamburg / DE
For all designated states
Greeve, Isabell
Oberstrasse 108
20143 Hamburg / DE
Former [2001/36]For all designated states
Nitsch, Roger
Guggerstrasse 19
8702 Zollikon / CH
For all designated states
Greeve, Isabell
Oberstrasse 108
20143 Hamburg / DE
Inventor(s)01 / Nitsch, Roger
Guggerstrasse 19
8702 Zollikon / CH
02 / Greeve, Isabell
Oberstrasse 108
20143 Hamburg / DE
 [2005/01]
Former [2001/36]01 / see applicant
...
Representative(s)dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB
Deichmannhaus am Dom
Bahnhofsvorplatz 1
50667 Köln / DE
[N/P]
Former [2001/36]Meyers, Hans-Wilhelm, Dr.Dipl.-Chem., et al
Patentanwälte von Kreisler-Selting-Werner Postfach 10 22 41
50462 Köln / DE
Application number, filing date99960975.312.11.1999
[2001/36]
WO1999EP08744
Priority number, dateEP1998012147812.11.1998         Original published format: EP 98121478
[2001/36]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO0029569
Date:25.05.2000
Language:EN
[2000/21]
Type: A1 Application with search report 
No.:EP1129191
Date:05.09.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 25.05.2000 takes the place of the publication of the European patent application.
[2001/36]
Type: B1 Patent specification 
No.:EP1129191
Date:22.03.2006
Language:EN
[2006/12]
Search report(s)International search report - published on:EP25.05.2000
ClassificationIPC:C12N15/12, C07K14/47, C12Q1/68, G01N33/68, A61K38/17
[2001/36]
CPC:
C07K14/4711 (EP,US); A61P1/00 (EP); A61P11/00 (EP);
A61P15/00 (EP); A61P21/00 (EP); A61P25/00 (EP);
A61P25/14 (EP); A61P25/16 (EP); A61P25/28 (EP);
A61P43/00 (EP); G01N33/6896 (EP,US) (-)
Designated contracting statesAT,   BE,   CH,   CY,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   LU,   MC,   NL,   PT,   SE [2001/36]
TitleGerman:VERFAHREN ZUR DIAGNOSE UND BEHANDLUNG NEUROLOGISCHER ERKRANKUNGEN[2001/36]
English:METHODS OF DIAGNOSING OR TREATING NEUROLOGICAL DISEASES[2001/36]
French:METHODES DE DIAGNOSTIC OU DE TRAITEMENT DE MALADIES NEUROLOGIQUES[2001/36]
Entry into regional phase04.05.2001National basic fee paid 
04.05.2001Designation fee(s) paid 
04.05.2001Examination fee paid 
Examination procedure20.05.2000Request for preliminary examination filed
International Preliminary Examining Authority: EP
04.05.2001Examination requested  [2001/36]
28.03.2002Despatch of a communication from the examining division (Time limit: M06)
26.09.2002Reply to a communication from the examining division
23.01.2004Despatch of a communication from the examining division (Time limit: M04)
28.05.2004Reply to a communication from the examining division
16.09.2005Communication of intention to grant the patent
13.01.2006Fee for grant paid
13.01.2006Fee for publishing/printing paid
Opposition(s)27.12.2006No opposition filed within time limit [2007/18]
Fees paidRenewal fee
28.11.2001Renewal fee patent year 03
28.11.2002Renewal fee patent year 04
26.11.2003Renewal fee patent year 05
13.11.2004Renewal fee patent year 06
28.11.2005Renewal fee patent year 07
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY22.03.2006
FI22.03.2006
GR23.06.2006
PT22.08.2006
MC30.11.2006
[2009/02]
Former [2008/29]FI22.03.2006
GR23.06.2006
PT22.08.2006
MC30.11.2006
Former [2008/21]GR23.06.2006
PT22.08.2006
MC30.11.2006
Former [2008/18]PT22.08.2006
MC30.11.2006
Former [2007/23]PT22.08.2006
Cited inInternational search[A]EP0814157  (SMITHKLINE BEECHAM CORP [US], et al) [A] 1-27,35-38 * page 3, line 40 - page 9, line 32 *;
 [X]  - EMBL NUCLEOTIDE SEQU, (19000101), Database accession no. D13643, XP002099607 [X] 5,8-13 * the whole document *
    [ ] - NOBUO NOMURA ET AL., "Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1", DNA RESEARCH, (1994), vol. 1, no. 1, pages 27 - 35, XP002099608 [ ] * abstract *

DOI:   http://dx.doi.org/10.1093/dnares/1.1.27
    [ ] - NOBUO NOMURA ET AL., "Prediction of the coding sequences of unidentified human genes. I. The coding sequences of 40 new genes (KIAA0001-KIAA0040) deduced by analysis of randomly sampled cDNA clones from human immature myeloid cell line KG-1 (Supplement)", DNA RESEARCH, (1994), vol. 1, no. 1, pages 47 - 56, XP002065816 [ ] * the whole document *

DOI:   http://dx.doi.org/10.1093/dnares/1.1.47
 [T]  - GREEVE, I. (1) ET AL, "Expression of Seladin -1, a novel neuroprotective gene with homologies to oxido-reductases is associated with selective vulnerability in Alzheimer's disease.", SOCIETY FOR NEUROSCIENCE ABSTRACTS, (1999) VOL. 25, NO. 1-2, PP. 546. MEETING INFO.: 29TH ANNUAL MEETING OF THE SOCIETY FOR NEUROSCIENCE, PART MIAMI BEACH, FLORIDA, USA OCTOBER 23-28, 1999 THE SOCIETY FOR NEUROSCIENC., XP002134188
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.